✦ LIBER ✦

Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C

✍ Scribed by Mohammed Rashid; Jonathon D. Mitchell; Matthew E. Cramp; Timothy J. S. Cross

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 55 KB
Volume: 51
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SAFE biopsy: A validated method for larg

SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C

✍ Giada Sebastiani; Philippe Halfon; Laurent Castera; Stanislas Pol; David L. Thom 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 1 views

The staging of liver fibrosis is pivotal for defining the prognosis and indications for therapy in hepatitis C. Although liver biopsy remains the gold standard, several noninvasive methods are under evaluation for clinical use. The aim of this study was to validate the recently described sequential

Does noninvasive staging of fibrosis cha

Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?

✍ Thomas Berg; Christoph Sarrazin; Holger Hinrichsen; Peter Buggisch; Tilman Gerla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Diffusion-weighted magnetic resonance im

Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C

✍ Maïté Lewin; Armelle Poujol-Robert; Pierre-Yves Boëlle; Dominique Wendum; Elisab 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 1 views

Liver biopsy is the gold standard for assessing fibrosis but has several limitations. We evaluated a noninvasive method, so-called diffusion-weighted magnetic resonance imaging (DWMRI), which measures the apparent diffusion coefficient (ADC) of water, for the diagnosis of liver fibrosis in patients

Validation of noninvasive methods for th

Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation

✍ Fabio Piscaglia; Alessandro Cucchetti; Eleonora Terzi; Alice Gianstefani 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Factors of accuracy of transient elastog

Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C

✍ Damien Lucidarme; Juliette Foucher; Brigitte Le Bail; Julien Vergniol; Laurent C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 2 views

The purpose of this study was to assess the influence of success rate and interquartile range on the accuracy of transient elastography for the diagnostic of fibrosis in hepatitis C virus infection. Two-hundred fifty-four consecutive patients had liver stiffness measurements and liver biopsy of at l

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub